David Steinberg
Stock Analyst at Jefferies
(2.81)
# 1,922
Out of 5,005 analysts
35
Total ratings
59.26%
Success rate
20.07%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Steinberg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BHC Bausch Health Companies | Downgrades: Hold | $12 → $8 | $6.68 | +19.76% | 7 | Feb 6, 2025 | |
| PRGO Perrigo Company | Upgrades: Buy | $45 → $63 | $22.51 | +179.88% | 8 | Sep 30, 2021 | |
| SUPN Supernus Pharmaceuticals | Upgrades: Buy | $25 → $40 | $48.35 | -17.27% | 11 | Apr 13, 2021 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $151 → $188 | $139.48 | +34.79% | 5 | Oct 9, 2020 | |
| OCUL Ocular Therapeutix | Initiates: Buy | $8 | $11.41 | -29.89% | 1 | Mar 17, 2020 | |
| SCPH scPharmaceuticals | Maintains: Buy | $26 → $12 | $5.67 | +111.64% | 2 | Jun 14, 2018 | |
| SVRA Savara | Initiates: Buy | $20 | $3.49 | +473.07% | 1 | Sep 22, 2017 |
Bausch Health Companies
Feb 6, 2025
Downgrades: Hold
Price Target: $12 → $8
Current: $6.68
Upside: +19.76%
Perrigo Company
Sep 30, 2021
Upgrades: Buy
Price Target: $45 → $63
Current: $22.51
Upside: +179.88%
Supernus Pharmaceuticals
Apr 13, 2021
Upgrades: Buy
Price Target: $25 → $40
Current: $48.35
Upside: -17.27%
Jazz Pharmaceuticals
Oct 9, 2020
Maintains: Buy
Price Target: $151 → $188
Current: $139.48
Upside: +34.79%
Ocular Therapeutix
Mar 17, 2020
Initiates: Buy
Price Target: $8
Current: $11.41
Upside: -29.89%
scPharmaceuticals
Jun 14, 2018
Maintains: Buy
Price Target: $26 → $12
Current: $5.67
Upside: +111.64%
Savara
Sep 22, 2017
Initiates: Buy
Price Target: $20
Current: $3.49
Upside: +473.07%